long intergenic non-protein coding RNA 2038Genealiases: []
Q-omics provides the consensus-scored LINC02038 profile across patient tissues and cancer cell-line models. LINC02038 expression is associated with patient survival in 23 of 34 cancer types, with the highest sampling consensus in KIRC. Among the 18 cancer types available for tumor–normal comparison, LINC02038 is differentially expressed in 12, with the highest sampling consensus in KIRC. Additionally, LINC02038 RNA expression shows 14,851 significant gene co-expression associations, with the highest sampling consensus in KIRP. Together, these results highlight KIRC, and KIRP as cancer lineages where LINC02038 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC02038 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC02038 survival associations across molecular data types. LINC02038 RNA expression shows survival associations in the most cancer types (23). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC02038 RNA expression–survival associations across cancer types. High LINC02038 expression shows unfavorable associations in KICH and TGCT, but favorable associations in KIRC, HNSC, READ and LUAD. The KIRC Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p < 0.001). Together, the overview and detailed table identify KIRC as the clearest survival context for LINC02038 RNA expression.
This table summarizes LINC02038 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 12. The strongest signals are observed in KIRC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC02038. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC02038 shows lower tumor expression in KIRC, COAD, KICH, LUSC, LUAD and KIRP. The KIRC box plot shows higher LINC02038 RNA expression in normal versus tumor tissue (log2 FC = −2.064, t-test p < 0.001).
This table shows molecular features associated with LINC02038 in patient tissues and cancer cell lines. In patient samples, LINC02038 shows the broadest associations at the RNA and protein expression levels, with KIRP recurring as the lineage with the largest associated feature set.
